Acting Now
The 3 pillars for disease prevention, control, and patient management include public health, clinical medicine, and laboratory medicine. However, laboratory medicine is the most neglected pillar in the developing countries, yet is relied on heavily for clinical decision making and for disease surveillance and control. The recent vast increase in funding for global health development 1,2 from the US President's Emergency Plan for AIDS Relief, President Obama's Global Health Initiative, the World Bank's laboratory strengthening efforts in East Africa, and other bilateral donors offered a monumental opportunity to act now, act decisively, to end the neglect of laboratory systems and services in global health.
Quality laboratory services and systems constitute the foundation for strengthening health systems, as the primary goal of laboratory medicine is to provide information that is critical to assist medical decision making for the best health care. Few developing countries have established laboratory standards that are affordable and easy to implement and monitor. In this regard, the Kigali meeting, which launched the laboratory management tool called "Strengthening Laboratory Management Toward Accreditation" (SLMTA) and the newly established WHO AFRO accreditation process, is a landmark event that laid a road map for strengthening laboratory systems in Africa leading to accreditation. 3 However, to achieve this goal, the international community must act collectively, with strong leadership from the countries, to end the neglect of laboratory systems. 4 operational research. As discussed in this issue of the Journal and in next month's issue, to avoid setting up parallel laboratory systems and networks, the international community must act collectively to address laboratory strengthening in a holistic manner in the context of the countries' national laboratory strategic plans and policies. Olmsted and colleagues, 5 in this issue of the Journal, have shown that laboratory strategic plans, as recommended by the Maputo Declaration, are being developed in several countries 6 ; however, implementation will require the collective effort of all donors and implementing partners with country ownership and leadership. Some important questions that need to be urgently addressed include the cost of implementing laboratory plans and policies and return on investment and impact on the overall health systems.
Acting Differently With a Shifted Paradigm
To maximize the surge in funding for global health development and the focus on strengthening health systems, a shift in paradigm must occur. The international community and developing countries must recognize that to sustain laboratory efforts, clear indicators, such as the number of laboratories accredited in the public health sector, and indices must be established to measure our progress for strengthening laboratory systems and networks. Zeh et al, 7 in this issue of the Journal, demonstrate that the accredited laboratory has benefits to patients but also leads to clear financial gains. In addition, different approaches that focus on the "known donothing gaps" must be pursued, including the following: (1) bridging the gap between laboratory medicine and clinicians, through continuous medical laboratory education, as Peter et al 8 will discuss in the October 2010 issue of the Journal; (2) strengthening professional bodies such as an African society for laboratory medicine that will advocate for and uphold standards in the field; (3) implementation of competency and task-based management programs, such as the SLMTA 9 ; (4) implementation of mentorship programs by embedding experts within countries' laboratory networks for extended periods; and (5) development of local capacity and indigenous partners to ensure sustainability of the laboratory efforts.
In sum, novel approaches and strategies, such as SLMTA and accrediting laboratories using standards that are practical, affordable, and scalable, are required to strengthen integrated laboratory systems that are critical for fighting emerging and reemerging diseases in the 21st century.
